Skip to main content

Table 1

From: Cardiorespiratory effects of inhaled nitric oxide and moderate hypercapnia in an experimental model of single ventricle

 

BL

NC

NC-iNO

HC-I

HC-II

RAP (mmHg)

8.9 ± 0.9

10.6 ± 1.5

10.7 ± 1.4

11 ± 1.4

11.3 ± 1.5

PAP (mmHg)

 

23.1 ± 1.8

20.4 ± 1.5

23.6 ± 1.8

25.2 ± 2.1*

MAP (mmHg)

88 ± 5.9

53 ± 3.7#

51.5 ± 3.4#

48.6 ± 3#

46.4 ± 3.3#

Qp/Qs

 

0.94 ± 0.1

1.17 ± 0.1

0.89 ± 0.1*

0.98 ± 0.1

CO (l/min)

 

1.95 ± 0.1

1.89 ± 0.1

1.81 ± 0.1

1.63 ± 0.1

PVR (dyne.s.cm-5)

 

1504 ± 331

967 ± 148

1514 ± 246

1661 ± 188*

SaO2(%)

99.6 ± 0.1

77 ± 3.6#

79.7 ± 2.3#

74 ± 4.4#

74 ± 3.4#

SvO2(%)

89 ± 1.2

45 ± 3.5#

47 ± 2.4#

42 ± 3.2#

40 ± 2.1#*

  1. RAP, right atrial pressure; PAP, pulmonary artery pressure; MAP, mean arterial pressure; Qp, pulmonary artery flow; Qs, systemic flow; PVR, pulmonary vascular resistance; BL, baseline; NC, normocapnia; HC-I, hypercapnia 50 torr; HC-II, hypercapnia 60 torr; iNO, inhaled nitric oxide * P < 0.05 vs NC-iNO, #P < 0.01 vs BL
Back to article page

Critical Care

ISSN: 1364-8535